YA-101

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameYA-101
Drug Alias NameYA-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulatorsNACHT, LRR and PYD domains-containing protein 3 modulators
TargetsGlutamate [NMDA] receptorNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsSchizophreniaCognition DisordersDyskinesias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYoda Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesYoda Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSchizophreniaCognition DisordersDyskinesias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A